ProbiusDX
Fremont, US · Delaware corporation · 4 known investors
Probius is a deep tech company developing a bioanalytical platform based on Quantum Electrochemical Spectroscopy (QES), which translates a sample into a high-dimensional phenotypic signature or digital twin that can be analyzed in the cloud. The technology targets applications across pharmaceuticals, biotechnology, healthcare, and environmental monitoring, bridging biology and AI.
Founders & leadership
CG
Chaitanya GuptaExecutive Officer, Director
EQ
Emmanuel QuevyCo-founder & CEO
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$2.4MraisedAug 2025 · 21 investors · OtherRule 506(b)
▶$2.4MraisedAug 2025 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Chaitanya GuptaExecutive Officer, Director
- Emmanuel QuevyExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $2.4M
- Sales commissions
- $252K
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.